This compound is this compound, a brominated heterocyclic compound containing aromatic rings. It is primarily used as a pharmaceutical intermediate in the synthesis of kinase inhibitors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1201186-54-0
2,4-Dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine
pharmaceutical intermediate
Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
pharmaceutical intermediate
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
pharmaceutical intermediate
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate
pharmaceutical intermediate
(R)-1-(3-Chlorophenyl)ethanol
pharmaceutical intermediate
Ixazomib Impurity 1
pharmaceutical intermediate
N,N',N''-((((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(2-oxoethane-2,1-diyl))tris(2,5-dichlorobenzamide)
pharmaceutical intermediate
2-bromo-5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazine
UMZKBENCNNDLRF-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)N2C=CC3=NC(=CN=C32)Br
—